BioSpace News Archive

Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development (“R&D”) and manufacturing capabilities, today reported its

Rocket Science Health and Inez Jabalpurwala have teamed up to launch VINEx – a multi-disciplinary exploration of how viruses directly and indirectly affect the central nervous system (CNS), and the potential impact on brain health in the immediate and longer term.

Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, today reported financial results for the three and nine months ended June 30, 2020 and provided an update on its business.

Initiated a Phase 2 Open Angle Glaucoma Trial; Recruiting Ahead of Schedule Announced Partnership with I-SPY to Participate in a Clinical Trial to Treat ARDS in COVID-19 Patients Announced a Second Clinical Trial Funded in Part by the U.S. Military to Prevent ARDS in COVID-19 Patients Ended Second Quarter 2020 with $44.9 Million in Cash Conference Call Today, August 12, 2020 at 8:30 a.m. EDT

Biotricity Inc. (OTCQB : BTCY ), a medical diagnostic and consumer healthcare technology company, today announced that it has entered into an Agreement that establishes terms under which Biotricty will enter into a licensing agreement. Biotricity has negotiated to license, with the exclusive right to acquire MD Matrix and its telemedicine platform that includes real-time streaming of medical devices, making it a perfect fit for th

Assure Holdings Corp., a provider of intraoperative neuromonitoring services, is pleased to announce that it has signed an agreement with the largest commercial health insurer in the state of Michigan 1.

PD Theranostics, Inc., provider of AI-driven tools to improve clinical decision-making in serious diseases, and a Laidlaw Venture Partners (“LVP”) portfolio company, today issued the following investor update.

WishBone Medical, Inc., a leader in pediatric orthopedic medical devices, is pleased to announce the appointment of Jeff George, global healthcare executive and investor, to the company’s board of directors, effective August 12, 2020.

BioSurfaces, LLC announced today that it has entered into a supply agreement with Corning Incorporated. Under this agreement, Corning, one of the world’s leading innovators in cell culture tools, will supply its Transwell® permeable supports plates to BioSurfaces.

Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today reported financial and operating results for the second quarter ended June 30, 2020 . The Company’s six-month progress includes the development of several strategic initiatives, including gr